Home About us Editorial board Browse Articles Submit article Instructions Subscribe Contacts Login 
  • Users Online: 133
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 13  |  Issue : 1  |  Page : 1

Detection Of radiation-induced DNA damage in breast cancer patients by using gamma H2AX biomarker: A possible correlation with their body mass index


1 Department of Radiobiology, Sudan Atomic Energy Commission, Khartoum, Sudan
2 Department of Medical Physics, National Cancer Institute, University of Gezira, Wad Medani, Sudan
3 Radiation and Isotope Centre, Khartoum, Sudan
4 Department of Radiobiology, Sudan Atomic Energy Commission; Department of Biochemistry, Nile College, Khartoum, Sudan

Correspondence Address:
Alkhansa S Mahmoud
Department of Radiobiology, Sudan Atomic Energy Commission, Khartoum 11111
Sudan
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/genint.genint_1_22

Rights and Permissions

Radiotherapy is one of the most important options for treating breast cancer in humans. The development of biomarkers to monitor radiosensitivity is scarce. The aim of this study is to investigate the γH2AX levels in the human blood samples 0.5 h after radiotherapy compared to the levels before radiotherapy in breast cancer patients in relation to their respective body mass index (BMI). Blood plasma samples were collected from a total of 20 breast cancer patients before and after radiotherapy to measure γH2AX levels with an antibody against γH2AX based on enzyme-linked immunosorbent assay technique. The median BMI of the patients was 30 kg/m2. γH2AX was differentially expressed in breast cancer patients before radiotherapy. γH2AX levels significantly increased in 14 patients after radiotherapy (P = 0.006), whereas γH2AX levels decreased in three patients after radiotherapy, and three patients were excluded. There was no correlation between γH2AX values after radiotherapy and BMI (P = 0.5, r = 0.1). Our results suggest that γH2AX can be used by ELISA technique to measure γH2AX in the blood plasma of breast cancer patients undergoing radiotherapy and can be considered a biomarker of radiosensitivity.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed10633    
    Printed707    
    Emailed0    
    PDF Downloaded827    
    Comments [Add]    

Recommend this journal